
|Videos|April 10, 2022
Available Atopic Dermatitis Therapies for Pediatric Patients
Author(s)Miranda Hester
Robert Sidbury, MD, MPH, the division chief of dermatology at Seattle Childrens, expands on his AD overview from the 4th annual Revolutionizing Atopic Dermatitis (RAD) conference is being held from April 9 to 11 in Baltimore, Maryland.
Advertisement
Robert Sidbury, MD, MPH, the division chief of dermatology at Seattle Childrens, talks the best which medications are best used for mild-to-moderate AD vs moderate-to-severe AD in pediatric patients and more in this video interview.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
New Review Confirms How Nonmedicated Skin Care Vehicles Drive Clinical Improvement
2
Zasocitinib Shows High Skin Clearance at Hard-to-Treat Psoriasis Sites
3
Dermatology Times Spot Test: July 19, 2026
4
Soficitinib (ICP-332) Meets Primary Endpoint in Phase 3 Trial for Moderate to Severe AD
5












